世界のPD-L1バイオマーカー検査市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global PD-L1 Biomarker Testing Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4669
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、99ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、PD-L1バイオマーカー検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PD-L1 IHC 22C3アッセイ、PD-L1 IHC 28-8アッセイ、PD-L1（SP142）アッセイ、PD-L1（SP263）アッセイ）、用途別市場規模（病院、診断センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・PD-L1バイオマーカー検査の市場動向
・企業の競争状況、市場シェア
・PD-L1バイオマーカー検査の種類別市場規模と予測2016-2027（PD-L1 IHC 22C3アッセイ、PD-L1 IHC 28-8アッセイ、PD-L1（SP142）アッセイ、PD-L1（SP263）アッセイ）
・PD-L1バイオマーカー検査の用途別市場規模と予測2016-2027（病院、診断センター、その他）
・PD-L1バイオマーカー検査の北米市場規模2016-2027（アメリカ、カナダ）
・PD-L1バイオマーカー検査の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・PD-L1バイオマーカー検査のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・PD-L1バイオマーカー検査の中南米市場規模2016-2027（メキシコ、ブラジル）
・PD-L1バイオマーカー検査の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Agilent Technologies、Eli Lilly、AstraZeneca、Roche、Bristol-Myers Squibb、Merck、Pfizer）
・結論

Immunotherapy has the power to manage immune system, recognize the cancer cell and fight against it. Our immune system has T- cell that fight against diseases, infections including cancer. The cancer cell represents the protein known as PD-L1 protein. The PD-L1 protein binds to the receptor on the T cell. The PD-L1 protein, that is expressed on the cancer cell inactivate the T cell from attacking the cancer cell.

Market Analysis and Insights: Global PD-L1 Biomarker Testing Market
The global PD-L1 Biomarker Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global PD-L1 Biomarker Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global PD-L1 Biomarker Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global PD-L1 Biomarker Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global PD-L1 Biomarker Testing market.

Global PD-L1 Biomarker Testing Scope and Market Size
PD-L1 Biomarker Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global PD-L1 Biomarker Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
PD-L1 IHC 22C3 Assay
PD-L1 IHC 28-8 Assay
PD-L1 (SP142) Assay
PD-L1 (SP263) Assay

Segment by Application
Hospital
Diagnostic Center
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Agilent Technologies
Eli Lilly
AstraZeneca
Roche
Bristol-Myers Squibb
Merck
Pfizer

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global PD-L1 Biomarker Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 PD-L1 IHC 22C3 Assay
1.2.3 PD-L1 IHC 28-8 Assay
1.2.4 PD-L1 (SP142) Assay
1.2.5 PD-L1 (SP263) Assay
1.3 Market by Application
1.3.1 Global PD-L1 Biomarker Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Diagnostic Center
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global PD-L1 Biomarker Testing Market Perspective (2016-2027)
2.2 PD-L1 Biomarker Testing Growth Trends by Regions
2.2.1 PD-L1 Biomarker Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 PD-L1 Biomarker Testing Historic Market Share by Regions (2016-2021)
2.2.3 PD-L1 Biomarker Testing Forecasted Market Size by Regions (2022-2027)
2.3 PD-L1 Biomarker Testing Industry Dynamic
2.3.1 PD-L1 Biomarker Testing Market Trends
2.3.2 PD-L1 Biomarker Testing Market Drivers
2.3.3 PD-L1 Biomarker Testing Market Challenges
2.3.4 PD-L1 Biomarker Testing Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top PD-L1 Biomarker Testing Players by Revenue
3.1.1 Global Top PD-L1 Biomarker Testing Players by Revenue (2016-2021)
3.1.2 Global PD-L1 Biomarker Testing Revenue Market Share by Players (2016-2021)
3.2 Global PD-L1 Biomarker Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by PD-L1 Biomarker Testing Revenue
3.4 Global PD-L1 Biomarker Testing Market Concentration Ratio
3.4.1 Global PD-L1 Biomarker Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by PD-L1 Biomarker Testing Revenue in 2020
3.5 PD-L1 Biomarker Testing Key Players Head office and Area Served
3.6 Key Players PD-L1 Biomarker Testing Product Solution and Service
3.7 Date of Enter into PD-L1 Biomarker Testing Market
3.8 Mergers & Acquisitions, Expansion Plans

4 PD-L1 Biomarker Testing Breakdown Data by Type
4.1 Global PD-L1 Biomarker Testing Historic Market Size by Type (2016-2021)
4.2 Global PD-L1 Biomarker Testing Forecasted Market Size by Type (2022-2027)

5 PD-L1 Biomarker Testing Breakdown Data by Application
5.1 Global PD-L1 Biomarker Testing Historic Market Size by Application (2016-2021)
5.2 Global PD-L1 Biomarker Testing Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America PD-L1 Biomarker Testing Market Size (2016-2027)
6.2 North America PD-L1 Biomarker Testing Market Size by Type
6.2.1 North America PD-L1 Biomarker Testing Market Size by Type (2016-2021)
6.2.2 North America PD-L1 Biomarker Testing Market Size by Type (2022-2027)
6.2.3 North America PD-L1 Biomarker Testing Market Size by Type (2016-2027)
6.3 North America PD-L1 Biomarker Testing Market Size by Application
6.3.1 North America PD-L1 Biomarker Testing Market Size by Application (2016-2021)
6.3.2 North America PD-L1 Biomarker Testing Market Size by Application (2022-2027)
6.3.3 North America PD-L1 Biomarker Testing Market Size by Application (2016-2027)
6.4 North America PD-L1 Biomarker Testing Market Size by Country
6.4.1 North America PD-L1 Biomarker Testing Market Size by Country (2016-2021)
6.4.2 North America PD-L1 Biomarker Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe PD-L1 Biomarker Testing Market Size (2016-2027)
7.2 Europe PD-L1 Biomarker Testing Market Size by Type
7.2.1 Europe PD-L1 Biomarker Testing Market Size by Type (2016-2021)
7.2.2 Europe PD-L1 Biomarker Testing Market Size by Type (2022-2027)
7.2.3 Europe PD-L1 Biomarker Testing Market Size by Type (2016-2027)
7.3 Europe PD-L1 Biomarker Testing Market Size by Application
7.3.1 Europe PD-L1 Biomarker Testing Market Size by Application (2016-2021)
7.3.2 Europe PD-L1 Biomarker Testing Market Size by Application (2022-2027)
7.3.3 Europe PD-L1 Biomarker Testing Market Size by Application (2016-2027)
7.4 Europe PD-L1 Biomarker Testing Market Size by Country
7.4.1 Europe PD-L1 Biomarker Testing Market Size by Country (2016-2021)
7.4.2 Europe PD-L1 Biomarker Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific PD-L1 Biomarker Testing Market Size (2016-2027)
8.2 Asia-Pacific PD-L1 Biomarker Testing Market Size by Type
8.2.1 Asia-Pacific PD-L1 Biomarker Testing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific PD-L1 Biomarker Testing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific PD-L1 Biomarker Testing Market Size by Type (2016-2027)
8.3 Asia-Pacific PD-L1 Biomarker Testing Market Size by Application
8.3.1 Asia-Pacific PD-L1 Biomarker Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific PD-L1 Biomarker Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific PD-L1 Biomarker Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific PD-L1 Biomarker Testing Market Size by Region
8.4.1 Asia-Pacific PD-L1 Biomarker Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific PD-L1 Biomarker Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America PD-L1 Biomarker Testing Market Size (2016-2027)
9.2 Latin America PD-L1 Biomarker Testing Market Size by Type
9.2.1 Latin America PD-L1 Biomarker Testing Market Size by Type (2016-2021)
9.2.2 Latin America PD-L1 Biomarker Testing Market Size by Type (2022-2027)
9.2.3 Latin America PD-L1 Biomarker Testing Market Size by Type (2016-2027)
9.3 Latin America PD-L1 Biomarker Testing Market Size by Application
9.3.1 Latin America PD-L1 Biomarker Testing Market Size by Application (2016-2021)
9.3.2 Latin America PD-L1 Biomarker Testing Market Size by Application (2022-2027)
9.3.3 Latin America PD-L1 Biomarker Testing Market Size by Application (2016-2027)
9.4 Latin America PD-L1 Biomarker Testing Market Size by Country
9.4.1 Latin America PD-L1 Biomarker Testing Market Size by Country (2016-2021)
9.4.2 Latin America PD-L1 Biomarker Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa PD-L1 Biomarker Testing Market Size (2016-2027)
10.2 Middle East & Africa PD-L1 Biomarker Testing Market Size by Type
10.2.1 Middle East & Africa PD-L1 Biomarker Testing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa PD-L1 Biomarker Testing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa PD-L1 Biomarker Testing Market Size by Type (2016-2027)
10.3 Middle East & Africa PD-L1 Biomarker Testing Market Size by Application
10.3.1 Middle East & Africa PD-L1 Biomarker Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa PD-L1 Biomarker Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa PD-L1 Biomarker Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa PD-L1 Biomarker Testing Market Size by Country
10.4.1 Middle East & Africa PD-L1 Biomarker Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa PD-L1 Biomarker Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Agilent Technologies
11.1.1 Agilent Technologies Company Details
11.1.2 Agilent Technologies Business Overview
11.1.3 Agilent Technologies PD-L1 Biomarker Testing Introduction
11.1.4 Agilent Technologies Revenue in PD-L1 Biomarker Testing Business (2016-2021)
11.1.5 Agilent Technologies Recent Development
11.2 Eli Lilly
11.2.1 Eli Lilly Company Details
11.2.2 Eli Lilly Business Overview
11.2.3 Eli Lilly PD-L1 Biomarker Testing Introduction
11.2.4 Eli Lilly Revenue in PD-L1 Biomarker Testing Business (2016-2021)
11.2.5 Eli Lilly Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Details
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca PD-L1 Biomarker Testing Introduction
11.3.4 AstraZeneca Revenue in PD-L1 Biomarker Testing Business (2016-2021)
11.3.5 AstraZeneca Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche PD-L1 Biomarker Testing Introduction
11.4.4 Roche Revenue in PD-L1 Biomarker Testing Business (2016-2021)
11.4.5 Roche Recent Development
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Details
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb PD-L1 Biomarker Testing Introduction
11.5.4 Bristol-Myers Squibb Revenue in PD-L1 Biomarker Testing Business (2016-2021)
11.5.5 Bristol-Myers Squibb Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck PD-L1 Biomarker Testing Introduction
11.6.4 Merck Revenue in PD-L1 Biomarker Testing Business (2016-2021)
11.6.5 Merck Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer PD-L1 Biomarker Testing Introduction
11.7.4 Pfizer Revenue in PD-L1 Biomarker Testing Business (2016-2021)
11.7.5 Pfizer Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global PD-L1 Biomarker Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of PD-L1 IHC 22C3 Assay
Table 3. Key Players of PD-L1 IHC 28-8 Assay
Table 4. Key Players of PD-L1 (SP142) Assay
Table 5. Key Players of PD-L1 (SP263) Assay
Table 6. Global PD-L1 Biomarker Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global PD-L1 Biomarker Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global PD-L1 Biomarker Testing Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global PD-L1 Biomarker Testing Market Share by Regions (2016-2021)
Table 10. Global PD-L1 Biomarker Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global PD-L1 Biomarker Testing Market Share by Regions (2022-2027)
Table 12. PD-L1 Biomarker Testing Market Trends
Table 13. PD-L1 Biomarker Testing Market Drivers
Table 14. PD-L1 Biomarker Testing Market Challenges
Table 15. PD-L1 Biomarker Testing Market Restraints
Table 16. Global PD-L1 Biomarker Testing Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global PD-L1 Biomarker Testing Market Share by Players (2016-2021)
Table 18. Global Top PD-L1 Biomarker Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in PD-L1 Biomarker Testing as of 2020)
Table 19. Ranking of Global Top PD-L1 Biomarker Testing Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by PD-L1 Biomarker Testing Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players PD-L1 Biomarker Testing Product Solution and Service
Table 23. Date of Enter into PD-L1 Biomarker Testing Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global PD-L1 Biomarker Testing Market Size by Type (2016-2021) (US$ Million)
Table 26. Global PD-L1 Biomarker Testing Revenue Market Share by Type (2016-2021)
Table 27. Global PD-L1 Biomarker Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global PD-L1 Biomarker Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global PD-L1 Biomarker Testing Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global PD-L1 Biomarker Testing Revenue Market Share by Application (2016-2021)
Table 31. Global PD-L1 Biomarker Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global PD-L1 Biomarker Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America PD-L1 Biomarker Testing Market Size by Type (2016-2021) (US$ Million)
Table 34. North America PD-L1 Biomarker Testing Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America PD-L1 Biomarker Testing Market Size by Application (2016-2021) (US$ Million)
Table 36. North America PD-L1 Biomarker Testing Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America PD-L1 Biomarker Testing Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America PD-L1 Biomarker Testing Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe PD-L1 Biomarker Testing Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe PD-L1 Biomarker Testing Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe PD-L1 Biomarker Testing Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe PD-L1 Biomarker Testing Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe PD-L1 Biomarker Testing Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe PD-L1 Biomarker Testing Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific PD-L1 Biomarker Testing Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific PD-L1 Biomarker Testing Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific PD-L1 Biomarker Testing Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific PD-L1 Biomarker Testing Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific PD-L1 Biomarker Testing Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific PD-L1 Biomarker Testing Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America PD-L1 Biomarker Testing Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America PD-L1 Biomarker Testing Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America PD-L1 Biomarker Testing Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America PD-L1 Biomarker Testing Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America PD-L1 Biomarker Testing Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America PD-L1 Biomarker Testing Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa PD-L1 Biomarker Testing Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa PD-L1 Biomarker Testing Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa PD-L1 Biomarker Testing Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa PD-L1 Biomarker Testing Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa PD-L1 Biomarker Testing Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa PD-L1 Biomarker Testing Market Size by Country (2022-2027) & (US$ Million)
Table 63. Agilent Technologies Company Details
Table 64. Agilent Technologies Business Overview
Table 65. Agilent Technologies PD-L1 Biomarker Testing Product
Table 66. Agilent Technologies Revenue in PD-L1 Biomarker Testing Business (2016-2021) & (US$ Million)
Table 67. Agilent Technologies Recent Development
Table 68. Eli Lilly Company Details
Table 69. Eli Lilly Business Overview
Table 70. Eli Lilly PD-L1 Biomarker Testing Product
Table 71. Eli Lilly Revenue in PD-L1 Biomarker Testing Business (2016-2021) & (US$ Million)
Table 72. Eli Lilly Recent Development
Table 73. AstraZeneca Company Details
Table 74. AstraZeneca Business Overview
Table 75. AstraZeneca PD-L1 Biomarker Testing Product
Table 76. AstraZeneca Revenue in PD-L1 Biomarker Testing Business (2016-2021) & (US$ Million)
Table 77. AstraZeneca Recent Development
Table 78. Roche Company Details
Table 79. Roche Business Overview
Table 80. Roche PD-L1 Biomarker Testing Product
Table 81. Roche Revenue in PD-L1 Biomarker Testing Business (2016-2021) & (US$ Million)
Table 82. Roche Recent Development
Table 83. Bristol-Myers Squibb Company Details
Table 84. Bristol-Myers Squibb Business Overview
Table 85. Bristol-Myers Squibb PD-L1 Biomarker Testing Product
Table 86. Bristol-Myers Squibb Revenue in PD-L1 Biomarker Testing Business (2016-2021) & (US$ Million)
Table 87. Bristol-Myers Squibb Recent Development
Table 88. Merck Company Details
Table 89. Merck Business Overview
Table 90. Merck PD-L1 Biomarker Testing Product
Table 91. Merck Revenue in PD-L1 Biomarker Testing Business (2016-2021) & (US$ Million)
Table 92. Merck Recent Development
Table 93. Pfizer Company Details
Table 94. Pfizer Business Overview
Table 95. Pfizer PD-L1 Biomarker Testing Product
Table 96. Pfizer Revenue in PD-L1 Biomarker Testing Business (2016-2021) & (US$ Million)
Table 97. Pfizer Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global PD-L1 Biomarker Testing Market Share by Type: 2020 VS 2027
Figure 2. PD-L1 IHC 22C3 Assay Features
Figure 3. PD-L1 IHC 28-8 Assay Features
Figure 4. PD-L1 (SP142) Assay Features
Figure 5. PD-L1 (SP263) Assay Features
Figure 6. Global PD-L1 Biomarker Testing Market Share by Application: 2020 VS 2027
Figure 7. Hospital Case Studies
Figure 8. Diagnostic Center Case Studies
Figure 9. Others Case Studies
Figure 10. PD-L1 Biomarker Testing Report Years Considered
Figure 11. Global PD-L1 Biomarker Testing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global PD-L1 Biomarker Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global PD-L1 Biomarker Testing Market Share by Regions: 2020 VS 2027
Figure 14. Global PD-L1 Biomarker Testing Market Share by Regions (2022-2027)
Figure 15. Global PD-L1 Biomarker Testing Market Share by Players in 2020
Figure 16. Global Top PD-L1 Biomarker Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in PD-L1 Biomarker Testing as of 2020
Figure 17. The Top 10 and 5 Players Market Share by PD-L1 Biomarker Testing Revenue in 2020
Figure 18. Global PD-L1 Biomarker Testing Revenue Market Share by Type (2016-2021)
Figure 19. Global PD-L1 Biomarker Testing Revenue Market Share by Type (2022-2027)
Figure 20. North America PD-L1 Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America PD-L1 Biomarker Testing Market Share by Type (2016-2027)
Figure 22. North America PD-L1 Biomarker Testing Market Share by Application (2016-2027)
Figure 23. North America PD-L1 Biomarker Testing Market Share by Country (2016-2027)
Figure 24. United States PD-L1 Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada PD-L1 Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe PD-L1 Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe PD-L1 Biomarker Testing Market Share by Type (2016-2027)
Figure 28. Europe PD-L1 Biomarker Testing Market Share by Application (2016-2027)
Figure 29. Europe PD-L1 Biomarker Testing Market Share by Country (2016-2027)
Figure 30. Germany PD-L1 Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France PD-L1 Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. PD-L1 Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy PD-L1 Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia PD-L1 Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic PD-L1 Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific PD-L1 Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific PD-L1 Biomarker Testing Market Share by Type (2016-2027)
Figure 38. Asia-Pacific PD-L1 Biomarker Testing Market Share by Application (2016-2027)
Figure 39. Asia-Pacific PD-L1 Biomarker Testing Market Share by Region (2016-2027)
Figure 40. China PD-L1 Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan PD-L1 Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea PD-L1 Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia PD-L1 Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India PD-L1 Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia PD-L1 Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America PD-L1 Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America PD-L1 Biomarker Testing Market Share by Type (2016-2027)
Figure 48. Latin America PD-L1 Biomarker Testing Market Share by Application (2016-2027)
Figure 49. Latin America PD-L1 Biomarker Testing Market Share by Country (2016-2027)
Figure 50. Mexico PD-L1 Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil PD-L1 Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa PD-L1 Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa PD-L1 Biomarker Testing Market Share by Type (2016-2027)
Figure 54. Middle East & Africa PD-L1 Biomarker Testing Market Share by Application (2016-2027)
Figure 55. Middle East & Africa PD-L1 Biomarker Testing Market Share by Country (2016-2027)
Figure 56. Turkey PD-L1 Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia PD-L1 Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE PD-L1 Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Agilent Technologies Revenue Growth Rate in PD-L1 Biomarker Testing Business (2016-2021)
Figure 60. Eli Lilly Revenue Growth Rate in PD-L1 Biomarker Testing Business (2016-2021)
Figure 61. AstraZeneca Revenue Growth Rate in PD-L1 Biomarker Testing Business (2016-2021)
Figure 62. Roche Revenue Growth Rate in PD-L1 Biomarker Testing Business (2016-2021)
Figure 63. Bristol-Myers Squibb Revenue Growth Rate in PD-L1 Biomarker Testing Business (2016-2021)
Figure 64. Merck Revenue Growth Rate in PD-L1 Biomarker Testing Business (2016-2021)
Figure 65. Pfizer Revenue Growth Rate in PD-L1 Biomarker Testing Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

以下、関連資料のご紹介

世界の薬力学的バイオマーカー試験市場規模・現状・予測（2021年-2027年）

Global Pharmacodynamic Biomarker Testing Market Size, Status and Forecast 2021-2027
QFJ1-4704 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、薬力学的バイオマーカー試験の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（LC-MS、MS）、用途別市場規模（病院、診断センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国...

世界の臨床バイオマーカー検査市場規模・現状・予測（2021年-2027年）

Global Clinical Biomarker Testing Market Size, Status and Forecast 2021-2027
QFJ1-4023 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、臨床バイオマーカー検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（がん、代謝、感染症、循環器、神経、免疫疾患）、用途別市場規模（創薬、ニュートリゲノミクス、毒物学検査、個別化医療、機能ゲノミクス）...

世界のST2バイオマーカー市場規模・現状・予測（2021年-2027年）

Global ST2 Biomarker Market Size, Status and Forecast 2021-2027
QFJ1-4898 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、ST2バイオマーカーの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ELISAベースST2バイオマーカー、免疫クロマトグラフィーベースST2バイオマーカー）、用途別市場規模（病院、診断センター、外来手...

世界のPD-1＆PD-L1免疫療法市場規模・現状・予測（2021年-2027年）

Global PD-1 and PD-L1 Immunotherapy Market Size, Status and Forecast 2021-2027
QFJ1-4668 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、PD-1＆PD-L1免疫療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PD-1阻害剤、PD-L1阻害剤）、用途別市場規模（固形腫瘍、血液関連腫瘍）、主要地域別市場規模（北米、アメリカ、欧州、アジ...

世界のPD-1＆PD-L1抗体市場規模・現状・予測（2021年-2027年）

Global PD-1 and PD-L1 Antibody Market Size, Status and Forecast 2021-2027
QFJ1-4667 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、PD-1＆PD-L1抗体の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PD-1阻害剤、PD-L1阻害剤）、用途別市場規模（固形腫瘍、血液関連腫瘍）、主要地域別市場規模（北米、アメリカ、欧州、アジア、...

世界の脳バイオマーカー市場規模・現状・予測（2021年-2027年）

Global Brain Biomarker Market Size, Status and Forecast 2021-2027
QFJ1-3930 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、脳バイオマーカーの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（バイオマーカー検査キット、バイオマーカー分析装置）、用途別市場規模（病院、外来外科センター、診断研究所）、主要地域別市場規模（北米、アメ...

世界の腎臓バイオマーカー市場規模・現状・予測（2021年-2027年）

Global Renal Biomarker Market Size, Status and Forecast 2021-2027
QFJ1-4807 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、腎臓バイオマーカーの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（機能性バイオマーカー、アップレギュレート化タンパク質、その他）、用途別市場規模（病院、診断研究所、その他）、主要地域別市場規模（北米、...

世界のデジタルバイオマーカー市場規模・現状・予測（2021年-2027年）

Global Digital Biomarker Market Size, Status and Forecast 2021-2027
QFJ1-4129 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、デジタルバイオマーカーの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（安全性バイオマーカー、検証性バイオマーカー、有効性バイオマーカー）、用途別市場規模（睡眠＆運動、心臓血管、気分＆行動、痛み管理、呼...

世界の標的バイオマーカー市場規模・現状・予測（2021年-2027年）

Global Targeted Biomarker Market Size, Status and Forecast 2021-2027
QFJ1-4933 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、標的バイオマーカーの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（安全性バイオマーカー、有効性バイオマーカー、検証バイオマーカー）、用途別市場規模（診断開発、創薬・開発、個別化医療、疾病リスク評価、そ...

世界の腫瘍バイオマーカー市場規模・現状・予測（2021年-2027年）

Global Oncology Biomarker Market Size, Status and Forecast 2021-2027
QFJ1-4604 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、腫瘍バイオマーカーの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（血液がん、固形腫瘍、その他）、用途別市場規模（診断、創薬・開発、予後、リスクアセスメント、その他）、主要地域別市場規模（北米、アメリカ...

世界の酵素免疫測定法（ELISA）検査市場規模・現状・予測（2021年-2027年） Enzyme-linked immunosorbent assay (ELISA) is mainly used to measure antibodies, antigens, proteins, and glycoproteins in biological samples. Hospitals and diagnostic centers were the major end-users to the ELISA test market. The demand ELISA testing in this end-user segment is mainly due to factors …
世界の糖尿病アッセイ市場規模・現状・予測（2021年-2027年） Diabetics cause serious damage to the heart, blood vessels, eyes, kidney and nerves. High risk of cardiac disorders associated with diabetes demands efficient testing and diagnosis options. Diabetics assays are used for diagnostics and monitoring who are at risk of developing diabetes. Market Analys…
世界のマイクロRNA配列決定＆アッセイ市場規模・現状・予測（2021年-2027年） MicroRNA sequencing (miRNA-seq), a type of RNA-Seq, is the use of next-generation sequencing or massively parallel high-throughput DNA sequencing to sequence microRNAs, also called miRNAs. miRNA-seq differs from other forms of RNA-seq in that input material is often enriched for small RNAs. miRNA-se…
原油アッセイ試験のグローバル市場：規模・現状・予測2019-2025 A crude oil assay is essentially the chemical evaluation of crude oil feedstocks by petroleum testing laboratories. Each crude oil type has unique molecular, chemical characteristics. No crude oil type is identical and there are crucial differences in crude oil quality. The results of crude oil assa…
原油アッセイ試験のグローバル市場：規模・現状・予測2019-2025 A crude oil assay is essentially the chemical evaluation of crude oil feedstocks by petroleum testing laboratories. Each crude oil type has unique molecular, chemical characteristics. No crude oil type is identical and there are crucial differences in crude oil quality. The results of crude oil assa…